Oxford vaccine trial pause isn’t bad news – it’s the process working
By Clare Wilson Michelle D’Urbano The has been great alarm over the news that a trial of a vaccine candidate for the coronavirus, from the University of Oxford and drug firm AstraZeneca, has had to be put on hold after a participant developed strange neurological symptoms. It might seem a cause for concern, but, in… Read More »